Study Review – CAPTIVATE study update: Long-term efficacy and safety of fixed duration ibrutinib–venetoclax in patients with CLL or SLL

As part of our ongoing aim to bring you reports of new developments, we have added a study review which summarises key results from the fixed-duration cohort of the CAPTIVATE study and presents updated data from the 5.5-year follow-up analysis.

Independent commentary for the review has been provided by Dr Monique Menzies Wojtowicz, a haematologist with special interests in lymphoma, clinical trials research, transfusion and medical education.

 

Please login below to download this issue (PDF)

Subscribe